Opti Capital Management

Opti Capital Management as of June 30, 2019

Portfolio Holdings for Opti Capital Management

Opti Capital Management holds 30 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Repligen Corp Note 2.125% 6/0 (Principal) 11.6 $70M 26k 2712.40
Caesars Entmt Corp Note 5.000%10/0 (Principal) 8.1 $49M 29k 1717.20
Workday Note 1.500% 7/1 (Principal) 7.9 $48M 19k 2518.11
Ironwood Pharmaceuticals DBCV 2.250% 6/1 (Principal) 6.9 $42M 39k 1070.00
Twitter Note 0.250% 9/1 (Principal) 6.4 $39M 40k 993.99
Electronics For Imaging Note 0.750% 9/0 (Principal) 6.1 $37M 37k 996.87
Verint Sys Note 1.500% 6/0 (Principal) 5.9 $36M 33k 1074.39
Cypress Semiconductor Corp Note 4.500% 1/1 (Principal) 5.3 $32M 19k 1679.30
Insulet Corp Note 1.250% 9/1 (Principal) 5.2 $32M 15k 2048.75
Finisar Corp Note 0.500%12/1 (Principal) 4.9 $30M 30k 978.13
J2 Global Note 3.250% 6/1 (Principal) 4.8 $29M 21k 1396.51
Nutanix Note 1/1 (Principal) 4.2 $26M 27k 932.65
Twitter Note 1.000% 9/1 (Principal) 3.5 $21M 22k 958.78
Rti Intl Metals Note 1.625%10/1 (Principal) 3.4 $21M 21k 1014.38
Fireeye Note 1.000% 6/0 (Principal) 2.8 $17M 17k 982.52
Fireeye Note 1.625% 6/0 (Principal) 2.6 $16M 17k 942.48
Allscripts Healthcare Solutn Note 1.250% 7/0 (Principal) 2.3 $14M 14k 1001.23
Microchip Technology Note 1.625% 2/1 (Principal) 1.4 $8.6M 4.9k 1753.07
National Health Invs Note 3.250% 4/0 (Principal) 0.8 $4.6M 4.0k 1160.50
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal) 0.7 $4.5M 5.0k 891.80
Pros Holdings Note 2.000% 6/0 (Principal) 0.7 $4.3M 3.1k 1375.08
Opko Health Note 4.500% 2/1 (Principal) 0.6 $3.9M 4.5k 877.56
Nuvasive Note 2.250% 3/1 (Principal) 0.6 $3.7M 3.2k 1136.24
Retrophin Note 2.500% 9/1 (Principal) 0.6 $3.4M 3.8k 901.87
Inphi Corp Note 0.750% 9/0 (Principal) 0.5 $3.3M 3.0k 1114.33
Ptc Therapeutics Note 3.000% 8/1 (Principal) 0.5 $3.3M 3.0k 1112.00
Interdigital Note 1.500% 3/0 (Principal) 0.5 $3.1M 3.0k 1038.67
Silver Std Res Note 2.875% 2/0 (Principal) 0.5 $3.0M 3.0k 1003.67
Clovis Oncology Note 1.250% 5/0 (Principal) 0.5 $2.8M 4.5k 625.56
Theravance Biopharma Note 3.250%11/0 (Principal) 0.2 $1.3M 1.5k 868.67